Contributing factors for XXXX after tubeless percutaneous nephrolithotomy.

@entity1 @entity548 @entity5990 @entity86 @entity221 @entity293
OBJECTIVE: To evaluate the contributing factors for @entity221 after tubeless percutaneous nephrolithotomy (PCNL). METHODS: Between May 2009 and December 2013, 395 tubeless PCNLs were performed at our hospital. After stone extraction, the @entity548 points were cauterized for hemostasis to enable tubeless modification. In @entity1 with troublesome @entity548 after cauterization, oxidized regenerated cellulose (Surgicel) strips were used to tamponade the access tract to facilitate @entity548 control. The contributory factors for @entity221 were evaluated by a retrospective chart review. RESULTS: Forty-four @entity1 (11.7%) developed @entity221 after tubeless PCNL. There was no difference in gender, age, and body mass index in the development of @entity221 . Episodes of febrile or septic @entity293 before PCNL were found to have occurred in 35 @entity1 , but the incidence of @entity86 was not significantly higher in these @entity1 . There is no significant difference in the mean stone size in @entity221 and nonfever @entity1 . @entity5990 were noted in 40 @entity1 , and their @entity221 rate was not significantly higher than @entity1 with nonstaghorn stone. The operation time is not significantly higher in the group with @entity293 . @entity1 with @entity86 had a high incidence of residual stones than the remaining @entity1 (38.9% vs 20.4%). There was no significant difference in incidence of @entity86 in @entity1 with struvite stones than @entity1 with nonstruvite stones. In @entity1 who received Surgicel packing, the incidence of @entity221 was not significantly higher. CONCLUSION: Incomplete stone extraction is a major contributing factor for the development of @entity221 after tubeless PCNL.
